Category Archives: The IPO Buzz

Fasten your seatbelts for a wild ride on the IPO highway. The technology sector is arriving. There is one deal on this week’s calendar plus three on next week’s; the filings continue to build, and their aftermarket performances are breathtaking.

 

 

The year’s first tech IPO popped with an opening-day moonshot, 2013’s last tech IPO lit up the sky with an opening-day starburst – and this week’s calendar features a tech IPO called Coupons.com.

 

There are only two deals on this week’s IPO calendar. Each has a message. One borrows from the wisdom of the racetrack. The other is a litmus test for what could be a wave of technology IPOs.

 

Last week’s traffic clearly signaled a shift in the trade winds sweeping through the Valley of IPOs. The cannonball run for the biotech sector looks like it’s over, but another sector is opening – technology.

 

 

Today’s “hot” IPO sector is starting to show signs of age. But if you listen to the wind, changes are in the works.

 

IPO players are ready to join the running of the biotechs through the canyons of Wall Street this week. Eleven of the 14 IPOs that are on the calendar are biotechs. And last week’s traffic was dominated by – yes – biotechs. Four of the eight IPOs that were priced were from this sector. A couple scored opening-day moonshots.

 

The days of the biotech and biopharma companies are coming to Wall Street. Three of the six IPOs on this week’s calendar are bio-IPOs and eight – yes, eight – of next week’s 10 IPOs are bio-IPOs. The emergence of this industrial sector should not be surprising. It has been sizzling.

 

The Martin Luther King, Jr. Day Holiday shortens this week’s trading sessions to four days and pushes the IPO traffic back to the end of the week. But something happened on the way to market. The pricing of a billion-dollar deal was accelerated. The usual reason for acceleration is strong investor demand.